Endovascular versus Medical Management of Acute Basilar Artery Occlusion: A Systematic Review and Meta-Analysis of the Randomized Controlled Trials

Background and Purpose The optimal management of patients with acute basilar artery occlusion (BAO) is uncertain. We aimed to evaluate the safety and efficacy of endovascular thrombectomy (EVT) compared to medical management (MM) for acute BAO through a meta-analysis of randomized controlled trials...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Journal of stroke Ročník 25; číslo 1; s. 81 - 91
Hlavní autori:	Abdalkader, Mohamad, Finitsis, Stephanos, Li, Chuanhui, Hu, Wei, Liu, Xinfeng, Ji, Xunming, Huo, Xiaochuan, Alemseged, Fana, Qiu, Zhongming, Strbian, Daniel, Puetz, Volker, Siegler, James E., Yaghi, Shadi, Asif, Kaiz, Klein, Piers, Zhu, Yuyou, Campbell, Bruce C.V., Chen, Hui-Sheng, Nagel, Simon, Tsivgoulis, Georgios, Miao, Zhongrong, Nogueira, Raul G., Jovin, Tudor G., Schonewille, Wouter J., Nguyen, Thanh N.
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Korea (South) Korean Stroke Society 01.01.2023 대한뇌졸중학회
Predmet:	acute basilar artery occlusion acute stroke meta-analysis posterior circulation Review 신경과학 Posterior circulation Acute basilar artery occlusion Acute stroke Meta-analysis
ISSN:	2287-6391, 2287-6405
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Abstract	Background and Purpose The optimal management of patients with acute basilar artery occlusion (BAO) is uncertain. We aimed to evaluate the safety and efficacy of endovascular thrombectomy (EVT) compared to medical management (MM) for acute BAO through a meta-analysis of randomized controlled trials (RCTs).Methods We performed a systematic review and meta-analysis of RCTs of patients with acute BAO. We analyzed the pooled effect of EVT compared to MM on the primary outcome (modified Rankin Scale [mRS] of 0–3 at 3 months), secondary outcome (mRS 0–2 at 3 months), symptomatic intracranial hemorrhage (sICH), and 3-month mortality rates. For each study, effect sizes were computed as odds ratios (ORs) with random effects and Mantel-Haenszel weighting.Results Four RCTs met inclusion criteria including 988 patients. There were higher odds of mRS of 0-3 at 90 days in the EVT versus MM group (45.1% vs. 29.1%, OR 1.99, 95% confidence interval [CI] 1.04–3.80; P=0.04). Patients receiving EVT had a higher sICH compared to MM (5.4% vs. 0.8%, OR 7.89, 95% CI 4.10–15.19; P<0.01). Mortality was lower in the EVT group (35.5% vs. 45.1%, OR 0.64, 95% CI 0.42–0.99; P=0.05). In an analysis of two trials with BAO patients and National Institutes of Health Stroke Scale (NIHSS) <10, there was no difference in 90-day outcomes between EVT versus MM.Conclusion In this systematic review and meta-analysis, EVT was associated with favorable outcome and decreased mortality in patients with BAO up to 24 hours from stroke symptoms compared to MM. The treatment effect in BAO patients with NIHSS <10 was less certain. Further studies are of interest to evaluate the efficacy of EVT in basilar occlusion patients with milder symptoms.
AbstractList	Background and Purpose The optimal management of patients with acute basilar artery occlusion (BAO) is uncertain. We aimed to evaluate the safety and efficacy of endovascular thrombectomy (EVT) compared to medical management (MM) for acute BAO through a meta-analysis of randomized controlled trials (RCTs).Methods We performed a systematic review and meta-analysis of RCTs of patients with acute BAO. We analyzed the pooled effect of EVT compared to MM on the primary outcome (modified Rankin Scale [mRS] of 0–3 at 3 months), secondary outcome (mRS 0–2 at 3 months), symptomatic intracranial hemorrhage (sICH), and 3-month mortality rates. For each study, effect sizes were computed as odds ratios (ORs) with random effects and Mantel-Haenszel weighting.Results Four RCTs met inclusion criteria including 988 patients. There were higher odds of mRS of 0-3 at 90 days in the EVT versus MM group (45.1% vs. 29.1%, OR 1.99, 95% confidence interval [CI] 1.04–3.80; P=0.04). Patients receiving EVT had a higher sICH compared to MM (5.4% vs. 0.8%, OR 7.89, 95% CI 4.10–15.19; P<0.01). Mortality was lower in the EVT group (35.5% vs. 45.1%, OR 0.64, 95% CI 0.42–0.99; P=0.05). In an analysis of two trials with BAO patients and National Institutes of Health Stroke Scale (NIHSS) <10, there was no difference in 90-day outcomes between EVT versus MM.Conclusion In this systematic review and meta-analysis, EVT was associated with favorable outcome and decreased mortality in patients with BAO up to 24 hours from stroke symptoms compared to MM. The treatment effect in BAO patients with NIHSS <10 was less certain. Further studies are of interest to evaluate the efficacy of EVT in basilar occlusion patients with milder symptoms. The optimal management of patients with acute basilar artery occlusion (BAO) is uncertain. We aimed to evaluate the safety and efficacy of endovascular thrombectomy (EVT) compared to medical management (MM) for acute BAO through a meta-analysis of randomized controlled trials (RCTs).BACKGROUND AND PURPOSEThe optimal management of patients with acute basilar artery occlusion (BAO) is uncertain. We aimed to evaluate the safety and efficacy of endovascular thrombectomy (EVT) compared to medical management (MM) for acute BAO through a meta-analysis of randomized controlled trials (RCTs).We performed a systematic review and meta-analysis of RCTs of patients with acute BAO. We analyzed the pooled effect of EVT compared to MM on the primary outcome (modified Rankin Scale [mRS] of 0-3 at 3 months), secondary outcome (mRS 0-2 at 3 months), symptomatic intracranial hemorrhage (sICH), and 3-month mortality rates. For each study, effect sizes were computed as odds ratios (ORs) with random effects and Mantel-Haenszel weighting.METHODSWe performed a systematic review and meta-analysis of RCTs of patients with acute BAO. We analyzed the pooled effect of EVT compared to MM on the primary outcome (modified Rankin Scale [mRS] of 0-3 at 3 months), secondary outcome (mRS 0-2 at 3 months), symptomatic intracranial hemorrhage (sICH), and 3-month mortality rates. For each study, effect sizes were computed as odds ratios (ORs) with random effects and Mantel-Haenszel weighting.Four RCTs met inclusion criteria including 988 patients. There were higher odds of mRS of 0-3 at 90 days in the EVT versus MM group (45.1% vs. 29.1%, OR 1.99, 95% confidence interval [CI] 1.04-3.80; P=0.04). Patients receiving EVT had a higher sICH compared to MM (5.4% vs. 0.8%, OR 7.89, 95% CI 4.10-15.19; P<0.01). Mortality was lower in the EVT group (35.5% vs. 45.1%, OR 0.64, 95% CI 0.42-0.99; P=0.05). In an analysis of two trials with BAO patients and National Institutes of Health Stroke Scale (NIHSS) <10, there was no difference in 90-day outcomes between EVT versus MM.RESULTSFour RCTs met inclusion criteria including 988 patients. There were higher odds of mRS of 0-3 at 90 days in the EVT versus MM group (45.1% vs. 29.1%, OR 1.99, 95% confidence interval [CI] 1.04-3.80; P=0.04). Patients receiving EVT had a higher sICH compared to MM (5.4% vs. 0.8%, OR 7.89, 95% CI 4.10-15.19; P<0.01). Mortality was lower in the EVT group (35.5% vs. 45.1%, OR 0.64, 95% CI 0.42-0.99; P=0.05). In an analysis of two trials with BAO patients and National Institutes of Health Stroke Scale (NIHSS) <10, there was no difference in 90-day outcomes between EVT versus MM.In this systematic review and meta-analysis, EVT was associated with favorable outcome and decreased mortality in patients with BAO up to 24 hours from stroke symptoms compared to MM. The treatment effect in BAO patients with NIHSS <10 was less certain. Further studies are of interest to evaluate the efficacy of EVT in basilar occlusion patients with milder symptoms.CONCLUSIONIn this systematic review and meta-analysis, EVT was associated with favorable outcome and decreased mortality in patients with BAO up to 24 hours from stroke symptoms compared to MM. The treatment effect in BAO patients with NIHSS <10 was less certain. Further studies are of interest to evaluate the efficacy of EVT in basilar occlusion patients with milder symptoms. Background and Purpose The optimal management of patients with acute basilar artery occlusion (BAO) is uncertain. We aimed to evaluate the safety and efficacy of endovascular thrombectomy (EVT) compared to medical management (MM) for acute BAO through a meta-analysis of randomized controlled trials (RCTs). Methods We performed a systematic review and meta-analysis of RCTs of patients with acute BAO. We analyzed the pooled effect of EVT compared to MM on the primary outcome (modified Rankin Scale [mRS] of 0–3 at 3 months), secondary outcome (mRS 0–2 at 3 months), symptomatic intracranial hemorrhage (sICH), and 3-month mortality rates. For each study, effect sizes were computed as odds ratios (ORs) with random effects and Mantel-Haenszel weighting. Results Four RCTs met inclusion criteria including 988 patients. There were higher odds of mRS of 0-3 at 90 days in the EVT versus MM group (45.1% vs. 29.1%, OR 1.99, 95% confidence interval [CI] 1.04–3.80; P=0.04). Patients receiving EVT had a higher sICH compared to MM (5.4% vs. 0.8%, OR 7.89, 95% CI 4.10–15.19; P<0.01). Mortality was lower in the EVT group (35.5% vs. 45.1%, OR 0.64, 95% CI 0.42–0.99; P=0.05). In an analysis of two trials with BAO patients and National Institutes of Health Stroke Scale (NIHSS) <10, there was no difference in 90-day outcomes between EVT versus MM. Conclusion In this systematic review and meta-analysis, EVT was associated with favorable outcome and decreased mortality in patients with BAO up to 24 hours from stroke symptoms compared to MM. The treatment effect in BAO patients with NIHSS <10 was less certain. Further studies are of interest to evaluate the efficacy of EVT in basilar occlusion patients with milder symptoms. KCI Citation Count: 0 The optimal management of patients with acute basilar artery occlusion (BAO) is uncertain. We aimed to evaluate the safety and efficacy of endovascular thrombectomy (EVT) compared to medical management (MM) for acute BAO through a meta-analysis of randomized controlled trials (RCTs). We performed a systematic review and meta-analysis of RCTs of patients with acute BAO. We analyzed the pooled effect of EVT compared to MM on the primary outcome (modified Rankin Scale [mRS] of 0-3 at 3 months), secondary outcome (mRS 0-2 at 3 months), symptomatic intracranial hemorrhage (sICH), and 3-month mortality rates. For each study, effect sizes were computed as odds ratios (ORs) with random effects and Mantel-Haenszel weighting. Four RCTs met inclusion criteria including 988 patients. There were higher odds of mRS of 0-3 at 90 days in the EVT versus MM group (45.1% vs. 29.1%, OR 1.99, 95% confidence interval [CI] 1.04-3.80; P=0.04). Patients receiving EVT had a higher sICH compared to MM (5.4% vs. 0.8%, OR 7.89, 95% CI 4.10-15.19; P<0.01). Mortality was lower in the EVT group (35.5% vs. 45.1%, OR 0.64, 95% CI 0.42-0.99; P=0.05). In an analysis of two trials with BAO patients and National Institutes of Health Stroke Scale (NIHSS) <10, there was no difference in 90-day outcomes between EVT versus MM. In this systematic review and meta-analysis, EVT was associated with favorable outcome and decreased mortality in patients with BAO up to 24 hours from stroke symptoms compared to MM. The treatment effect in BAO patients with NIHSS <10 was less certain. Further studies are of interest to evaluate the efficacy of EVT in basilar occlusion patients with milder symptoms.
Author	Nogueira, Raul G. Nguyen, Thanh N. Li, Chuanhui Puetz, Volker Yaghi, Shadi Finitsis, Stephanos Qiu, Zhongming Siegler, James E. Hu, Wei Campbell, Bruce C.V. Liu, Xinfeng Huo, Xiaochuan Chen, Hui-Sheng Miao, Zhongrong Ji, Xunming Nagel, Simon Abdalkader, Mohamad Schonewille, Wouter J. Klein, Piers Strbian, Daniel Jovin, Tudor G. Alemseged, Fana Zhu, Yuyou Asif, Kaiz Tsivgoulis, Georgios
AuthorAffiliation	Departments of Radiology and Neurology, Boston Medical Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA
AuthorAffiliation_xml	– name: Departments of Radiology and Neurology, Boston Medical Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA
Author_xml	– sequence: 1 givenname: Mohamad surname: Abdalkader fullname: Abdalkader, Mohamad – sequence: 2 givenname: Stephanos surname: Finitsis fullname: Finitsis, Stephanos – sequence: 3 givenname: Chuanhui surname: Li fullname: Li, Chuanhui – sequence: 4 givenname: Wei surname: Hu fullname: Hu, Wei – sequence: 5 givenname: Xinfeng surname: Liu fullname: Liu, Xinfeng – sequence: 6 givenname: Xunming surname: Ji fullname: Ji, Xunming – sequence: 7 givenname: Xiaochuan surname: Huo fullname: Huo, Xiaochuan – sequence: 8 givenname: Fana surname: Alemseged fullname: Alemseged, Fana – sequence: 9 givenname: Zhongming surname: Qiu fullname: Qiu, Zhongming – sequence: 10 givenname: Daniel surname: Strbian fullname: Strbian, Daniel – sequence: 11 givenname: Volker surname: Puetz fullname: Puetz, Volker – sequence: 12 givenname: James E. surname: Siegler fullname: Siegler, James E. – sequence: 13 givenname: Shadi surname: Yaghi fullname: Yaghi, Shadi – sequence: 14 givenname: Kaiz surname: Asif fullname: Asif, Kaiz – sequence: 15 givenname: Piers surname: Klein fullname: Klein, Piers – sequence: 16 givenname: Yuyou surname: Zhu fullname: Zhu, Yuyou – sequence: 17 givenname: Bruce C.V. surname: Campbell fullname: Campbell, Bruce C.V. – sequence: 18 givenname: Hui-Sheng surname: Chen fullname: Chen, Hui-Sheng – sequence: 19 givenname: Simon surname: Nagel fullname: Nagel, Simon – sequence: 20 givenname: Georgios surname: Tsivgoulis fullname: Tsivgoulis, Georgios – sequence: 21 givenname: Zhongrong surname: Miao fullname: Miao, Zhongrong – sequence: 22 givenname: Raul G. surname: Nogueira fullname: Nogueira, Raul G. – sequence: 23 givenname: Tudor G. surname: Jovin fullname: Jovin, Tudor G. – sequence: 24 givenname: Wouter J. orcidid: 0000-0002-4070-9730 surname: Schonewille fullname: Schonewille, Wouter J. – sequence: 25 givenname: Thanh N. orcidid: 0000-0002-2810-1685 surname: Nguyen fullname: Nguyen, Thanh N.
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/36746382$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002927685$$DAccess content in National Research Foundation of Korea (NRF)
BookMark	eNp1UlFv0zAQjtAQG2OvPCI_IqSWOImdhAekUG1QadOkUp6tq33p3Dn2sJOi8jf2h3HabWJI-OUs3_d957v7XidH1llMkrc0nbKK5R83LkyzNMumaV4y9iI5ybKqnPAiZUeP97ymx8lZCJs0norRqspeJcc5LwueV9lJcn9uldtCkIMBT7bowxDIFSotwZArsLDGDm1PXEsaOfRIvkDQI7TxPfoduZbSDEE7-4k05Psu9NhBryVZ4FbjLwJWRbUeJo0Fsws6jEL9DZJFzLhO_0ZFZs723hkTr0uvwYQ3ycs2Bjx7iKfJj4vz5ezb5PL663zWXE4kY2U_gQoqXuQMQeUKgSPjteJpzRGglZJWJedQFyvaUqp4W0pVZ6kqMskrxiUW-Wny4aBrfStupRYO9D6unbj1olks54KmlNK6ZhE8P4CVg42487oDv9sz9g_OrwX42LlBoVbjqItccsqLVYkrjkoipDktWqpQRq3PB627YdWNuTgAMM9En2esvomf2oq6pjQuMQq8fxDw7ueAoRedDhKNAYtuCCIryyLjJSvHJt_9XeupyKMFImB6AEjvQvDYPkFoKkabiWgzMdpM7G0WCcU_BKn7uPRxjaDN_2h_AGL72UA
CitedBy_id	crossref_primary_10_3390_ijms25020891 crossref_primary_10_1212_WNL_0000000000209926 crossref_primary_10_1161_JAHA_123_030713 crossref_primary_10_1177_23969873241257223 crossref_primary_10_3389_fneur_2025_1512399 crossref_primary_10_1177_17474930241267353 crossref_primary_10_1212_WNL_0000000000210086 crossref_primary_10_1227_neu_0000000000003035 crossref_primary_10_1161_STROKEAHA_125_051357 crossref_primary_10_1159_000539112 crossref_primary_10_1161_STROKEAHA_124_050389 crossref_primary_10_3390_jcm12206444 crossref_primary_10_1016_j_jstrokecerebrovasdis_2024_107651 crossref_primary_10_1161_STROKEAHA_124_049038 crossref_primary_10_1177_23969873231209616 crossref_primary_10_1007_s00415_024_12842_y crossref_primary_10_1227_neu_0000000000003160 crossref_primary_10_1161_STROKEAHA_122_040807 crossref_primary_10_1111_jon_13084 crossref_primary_10_1097_WCO_0000000000001234 crossref_primary_10_1212_WNL_0000000000209249 crossref_primary_10_1136_jnis_2024_022798 crossref_primary_10_1212_WNL_0000000000209324 crossref_primary_10_1177_15910199241272652 crossref_primary_10_1161_SVIN_123_000835 crossref_primary_10_1161_JAHA_123_032107 crossref_primary_10_1159_000540555 crossref_primary_10_1177_0271678X231187174 crossref_primary_10_1161_STROKEAHA_125_051485 crossref_primary_10_1136_bmj_2024_080489 crossref_primary_10_1007_s10143_024_02690_9 crossref_primary_10_1161_JAHA_123_033192 crossref_primary_10_1016_S0140_6736_24_02137_8 crossref_primary_10_1161_STROKEAHA_124_047568 crossref_primary_10_3390_jcm12072617 crossref_primary_10_1007_s15202_024_6191_1 crossref_primary_10_1161_SVIN_123_000885 crossref_primary_10_1161_SVIN_123_001017 crossref_primary_10_1161_STROKEAHA_123_043669 crossref_primary_10_1177_23969873241272517 crossref_primary_10_1177_15910199231175619 crossref_primary_10_1159_000539657 crossref_primary_10_1212_WNL_0000000000209827 crossref_primary_10_1227_neu_0000000000003736 crossref_primary_10_1136_jnis_2024_022609 crossref_primary_10_2147_JIR_S492095 crossref_primary_10_1001_jamanetworkopen_2025_15526 crossref_primary_10_3389_fneur_2025_1417188 crossref_primary_10_1136_jnis_2025_023620 crossref_primary_10_1055_s_0043_1771455 crossref_primary_10_1136_jnis_2024_022053 crossref_primary_10_1007_s00415_025_13144_7 crossref_primary_10_1016_S0140_6736_24_01410_7 crossref_primary_10_1212_WNL_0000000000213415 crossref_primary_10_1136_jnis_2023_020676 crossref_primary_10_1161_SVIN_123_001004 crossref_primary_10_1055_s_0043_1771210 crossref_primary_10_1177_02841851241255313 crossref_primary_10_1097_WCO_0000000000001337 crossref_primary_10_1212_WNL_0000000000209785 crossref_primary_10_1093_postmj_qgae136 crossref_primary_10_1177_15910199241265590 crossref_primary_10_1007_s11357_025_01887_0 crossref_primary_10_1016_j_clineuro_2024_108331 crossref_primary_10_1177_15910199241265397 crossref_primary_10_1111_cns_14513 crossref_primary_10_1016_j_neuchi_2024_101587 crossref_primary_10_1161_STROKEAHA_124_047383 crossref_primary_10_1177_23969873241234713 crossref_primary_10_1016_j_clineuro_2023_107824 crossref_primary_10_1177_15910199241285157 crossref_primary_10_1177_23969873231164790 crossref_primary_10_1111_ene_16380 crossref_primary_10_55994_ejcc_1539641 crossref_primary_10_1016_S0140_6736_24_00642_1 crossref_primary_10_3390_jcm13144153 crossref_primary_10_1007_s00415_024_12353_w crossref_primary_10_1016_j_jstrokecerebrovasdis_2023_107526 crossref_primary_10_1161_STROKEAHA_123_043487 crossref_primary_10_1161_STROKEAHA_122_041645 crossref_primary_10_1161_STROKEAHA_123_042674 crossref_primary_10_1177_17474930251332753
Cites_doi	10.1016/j.jstrokecerebrovasdis.2022.106804 10.1016/s1474-4422(09)70173-5 10.1016/j.neurad.2017.01.126 10.7326/0003-4819-151-4-200908180-00135 10.1161/strokeaha.114.004884 10.1161/svin.122.000538 10.1007/s12975-022-01008-5 10.1161/strokeaha.121.035948 10.1161/strokeaha.122.040807 10.5853/jos.2020.01788 10.1056/nejmoa1415061 10.1016/j.jemermed.2021.06.003 10.1016/j.neurad.2022.12.004 10.1161/circulationaha.121.058544 10.1212/wnl.0000000000200030 10.1136/bmj.n71 10.1016/s1474-4422(16)30177-6 10.1056/nejmoa2207576 10.1056/nejmoa1414792 10.1161/SVIN.122.000642 10.1186/1471-2288-14-25 10.1016/s0140-6736(16)00163-x 10.1056/nejmoa1214300 10.1159/000086121 10.1056/nejmoa1503780 10.1159/000108174 10.1186/s12883-019-1551-8 10.1056/nejmoa1414905 10.1111/ene.14751 10.1016/j.jstrokecerebrovasdis.2017.04.043 10.1002/ana.23904 10.1161/strokeaha.120.034019 10.1161/strokeaha.118.021106 10.1056/nejmoa1713973 10.1001/jamaneurol.2020.0156 10.1016/s0140-6736(21)01341-6 10.1056/nejmoa2206317 10.1161/strokeaha.122.041645
ContentType	Journal Article
Copyright	Copyright © 2023 Korean Stroke Society 2023
Copyright_xml	– notice: Copyright © 2023 Korean Stroke Society 2023
CorporateAuthor	on behalf of the BasilaR Artery Ischemia Network STudy of Endovascular versus Medical Management (BRAINSTEM) Group BasilaR Artery Ischemia Network STudy of Endovascular versus Medical Management (BRAINSTEM) Group
CorporateAuthor_xml	– name: on behalf of the BasilaR Artery Ischemia Network STudy of Endovascular versus Medical Management (BRAINSTEM) Group – name: BasilaR Artery Ischemia Network STudy of Endovascular versus Medical Management (BRAINSTEM) Group
DBID	AAYXX CITATION NPM 7X8 5PM DOA ACYCR
DOI	10.5853/jos.2022.03755
DatabaseName	CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals Korean Citation Index
DatabaseTitle	CrossRef PubMed MEDLINE - Academic
DatabaseTitleList	CrossRef MEDLINE - Academic PubMed
Database_xml	– sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
EISSN	2287-6405
EndPage	91
ExternalDocumentID	oai_kci_go_kr_ARTI_10111995 oai_doaj_org_article_db008543c6164b7eb6edcea0314f1dec PMC9911851 36746382 10_5853_jos_2022_03755
Genre	Journal Article Review
GroupedDBID	5-W 53G 8JR 8XY AAYXX ADBBV AENEX ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL CITATION DIK EF. GROUPED_DOAJ HYE KQ8 M48 OK1 PGMZT RPM ADRAZ NPM 7X8 5PM ACYCR
ID	FETCH-LOGICAL-c557t-a8a86435ead3dea6e569d6096eaafcc18766a94b1f11d6f7cd920d42c6856ce43
IEDL.DBID	DOA
ISICitedReferencesCount	88
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000933197800008&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	2287-6391
IngestDate	Fri Jan 26 03:33:31 EST 2024 Fri Oct 03 12:52:17 EDT 2025 Thu Aug 21 18:37:45 EDT 2025 Thu Jul 10 18:28:58 EDT 2025 Thu Jan 02 22:54:13 EST 2025 Sat Nov 29 01:42:39 EST 2025 Tue Nov 18 21:25:24 EST 2025
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	1
Keywords	Posterior circulation Acute basilar artery occlusion Acute stroke Meta-analysis
Language	English
License	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c557t-a8a86435ead3dea6e569d6096eaafcc18766a94b1f11d6f7cd920d42c6856ce43
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23
ORCID	0000-0002-4070-9730 0000-0002-2810-1685
OpenAccessLink	https://doaj.org/article/db008543c6164b7eb6edcea0314f1dec
PMID	36746382
PQID	2774267574
PQPubID	23479
PageCount	11
ParticipantIDs	nrf_kci_oai_kci_go_kr_ARTI_10111995 doaj_primary_oai_doaj_org_article_db008543c6164b7eb6edcea0314f1dec pubmedcentral_primary_oai_pubmedcentral_nih_gov_9911851 proquest_miscellaneous_2774267574 pubmed_primary_36746382 crossref_primary_10_5853_jos_2022_03755 crossref_citationtrail_10_5853_jos_2022_03755
PublicationCentury	2000
PublicationDate	2023-01-01
PublicationDateYYYYMMDD	2023-01-01
PublicationDate_xml	– month: 01 year: 2023 text: 2023-01-01 day: 01
PublicationDecade	2020
PublicationPlace	Korea (South)
PublicationPlace_xml	– name: Korea (South)
PublicationTitle	Journal of stroke
PublicationTitleAlternate	J Stroke
PublicationYear	2023
Publisher	Korean Stroke Society 대한뇌졸중학회
Publisher_xml	– name: Korean Stroke Society – name: 대한뇌졸중학회
References	ref13 ref35 ref12 ref34 ref15 ref14 ref36 ref31 ref30 ref11 ref33 ref10 ref32 ref2 ref17 ref39 ref16 ref38 ref19 Berkhemer (ref1) 2015 Nogueira (ref6) 2018 ref24 ref23 ref26 ref25 Liu (ref18) 2020 ref20 ref42 ref41 ref22 ref21 Guenego (ref37) 2021 ref28 ref27 ref29 ref8 ref7 ref9 ref4 ref3 ref5 ref40
References_xml	– ident: ref11 doi: 10.1016/j.jstrokecerebrovasdis.2022.106804 – ident: ref12 doi: 10.1016/s1474-4422(09)70173-5 – start-page: 11 volume-title: Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct year: 2018 ident: ref6 – ident: ref9 doi: 10.1016/j.neurad.2017.01.126 – start-page: e400 volume-title: Thrombectomy for basilar artery occlusion with mild symptoms year: 2021 ident: ref37 – ident: ref21 doi: 10.7326/0003-4819-151-4-200908180-00135 – ident: ref26 doi: 10.1161/strokeaha.114.004884 – ident: ref10 doi: 10.1161/svin.122.000538 – ident: ref16 doi: 10.1007/s12975-022-01008-5 – ident: ref25 doi: 10.1161/strokeaha.121.035948 – ident: ref30 doi: 10.1161/strokeaha.122.040807 – ident: ref32 doi: 10.5853/jos.2020.01788 – ident: ref5 doi: 10.1056/nejmoa1415061 – ident: ref17 doi: 10.1016/j.jemermed.2021.06.003 – ident: ref34 doi: 10.1016/j.neurad.2022.12.004 – ident: ref14 doi: 10.1161/circulationaha.121.058544 – ident: ref40 doi: 10.1212/wnl.0000000000200030 – ident: ref42 doi: 10.1136/bmj.n71 – ident: ref8 doi: 10.1016/s1474-4422(16)30177-6 – ident: ref20 doi: 10.1056/nejmoa2207576 – ident: ref2 doi: 10.1056/nejmoa1414792 – ident: ref41 doi: 10.1161/SVIN.122.000642 – ident: ref22 doi: 10.1186/1471-2288-14-25 – ident: ref28 doi: 10.1016/s0140-6736(16)00163-x – ident: ref24 doi: 10.1056/nejmoa1214300 – ident: ref23 doi: 10.1159/000086121 – ident: ref4 doi: 10.1056/nejmoa1503780 – ident: ref33 doi: 10.1159/000108174 – ident: ref39 doi: 10.1186/s12883-019-1551-8 – ident: ref3 doi: 10.1056/nejmoa1414905 – ident: ref38 doi: 10.1111/ene.14751 – ident: ref13 doi: 10.1016/j.jstrokecerebrovasdis.2017.04.043 – ident: ref31 doi: 10.1002/ana.23904 – ident: ref35 doi: 10.1161/strokeaha.120.034019 – ident: ref36 doi: 10.1161/strokeaha.118.021106 – start-page: 11 volume-title: A randomized trial of intraarterial treatment for acute ischemic stroke year: 2015 ident: ref1 – start-page: 115 volume-title: Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial year: 2020 ident: ref18 – ident: ref7 doi: 10.1056/nejmoa1713973 – ident: ref15 doi: 10.1001/jamaneurol.2020.0156 – ident: ref29 doi: 10.1016/s0140-6736(21)01341-6 – ident: ref19 doi: 10.1056/nejmoa2206317 – ident: ref27 doi: 10.1161/strokeaha.122.041645
SSID	ssj0000851882
Score	2.5247548
SecondaryResourceType	review_article
Snippet	Background and Purpose The optimal management of patients with acute basilar artery occlusion (BAO) is uncertain. We aimed to evaluate the safety and efficacy... The optimal management of patients with acute basilar artery occlusion (BAO) is uncertain. We aimed to evaluate the safety and efficacy of endovascular...
SourceID	nrf doaj pubmedcentral proquest pubmed crossref
SourceType	Open Website Open Access Repository Aggregation Database Index Database Enrichment Source
StartPage	81
SubjectTerms	acute basilar artery occlusion acute stroke meta-analysis posterior circulation Review 신경과학
Title	Endovascular versus Medical Management of Acute Basilar Artery Occlusion: A Systematic Review and Meta-Analysis of the Randomized Controlled Trials
URI	https://www.ncbi.nlm.nih.gov/pubmed/36746382 https://www.proquest.com/docview/2774267574 https://pubmed.ncbi.nlm.nih.gov/PMC9911851 https://doaj.org/article/db008543c6164b7eb6edcea0314f1dec https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002927685
Volume	25
WOSCitedRecordID	wos000933197800008&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
ispartofPNX	대한뇌졸중영문학회지, 2023, 25(1), 20, pp.81-91
journalDatabaseRights	– providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2287-6405 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000851882 issn: 2287-6391 databaseCode: DOA dateStart: 20130101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3LbtQwFLWgQogNKu8UqIxAYmU6zsNx2E2rVmVBQVCk2Vl-paQdkmomQSq_wQ9zb5wJM6iIDauMEidyck_sc-Mz5xLyyqeFB1ogmXHSsTTTnBXGSFZqzbXDKlfe9sUm8pMTOZsVH9dKfaEmLNgDhwe35wyygjSxAoi9wQoeqFvU6Lpecuctjr6TvFhLps6D-orLvlJUDCkBg2mYB8dGYMfJ3nmDRt1x_AYLwGYbM1Jv3A_zTL0or-Ocf0on1-aio21ydyCRdBo6f4_c8PV9cvv9sEz-gPw8rN2oMaUovOiWdFiSob8FL7Qp6dR2raf7ellh0ykKPK_oB2vnHX5Ge0un9PPo9UzDQgLVtYOrtZqtHE3wQkAk6Sc40nyrfnhHD4IEfg4_T3uMPyRfjg5PD47ZUH2B2SzLW6allkBXMoBa4rwWPhOFE5DxeK1LazkMo0IXqeEl506UuXVFPHFpbIXMhPVp8ohs1U3tnxBqc-mlk6WcCAsnZEY6E0ut48IabgofEbaKgLKDNTlWyJgrSFEwYgoipjBiqo9YRF6P7S-DKcdfW-5jQMdWaKbd7wCIqQFi6l8Qi8hLgIO6sFV_Pm7PGnWxUJByvEONHMf_uUfkxQouCl5RXHfRtW866A5Q7BgSszyNyOMAn7FDichTGALjiOQbwNro8eaRuvra24ADsweyxXf-xy0-JXfgoSXh29IzstUuOv-c3LLf22q52CU385nc7d-wX2f1LU0
linkProvider	Directory of Open Access Journals
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Endovascular+versus+Medical+Management+of+Acute+Basilar+Artery+Occlusion%3A+A+Systematic+Review+and+Meta-Analysis+of+the+Randomized+Controlled+Trials&rft.jtitle=Journal+of+stroke&rft.au=Abdalkader%2C+Mohamad&rft.au=Finitsis%2C+Stephanos&rft.au=Li%2C+Chuanhui&rft.au=Hu%2C+Wei&rft.date=2023-01-01&rft.issn=2287-6391&rft.eissn=2287-6405&rft.volume=25&rft.issue=1&rft.spage=81&rft.epage=91&rft_id=info:doi/10.5853%2Fjos.2022.03755&rft.externalDBID=n%2Fa&rft.externalDocID=10_5853_jos_2022_03755
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2287-6391&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2287-6391&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2287-6391&client=summon